The Board of Directors of the HWGB wishes to announce that its wholly-owned subsidiary, HWGB Biotech Sdn Bhd (formerly known as HWG Consortium Sdn Bhd) (“HWGB Biotech”) had on 6 August 2020 entered into a memorandum of agreement with E-Mo Biology Inc. (“EBI”) (herein after known as the “Parties”) for the purposes of recording the Parties’ intentions with respect to a proposed collaboration to undertake phase IV clinical trials for a new indication which proposes the use of existing poliomyelitis virus vaccines for prevention of COVID-19 (“New Indication”) (subject to the pre-approval or exemption from the United States Food and Drug Administration for the Initial Investigational New Drug Application) and the research and development, testing, registration, manufacturing and commercialisation of the New Indication.
Look at the directors face you know they are goreng kaki la, morning they will push the price to limit up, Monday people will follow and then they will sell to you.....Be careful la, want to goreng also must see news make sense or not! Walauwei
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
hunterrrrr
210 posts
Posted by hunterrrrr > 2020-08-04 15:59 | Report Abuse
this counter alive just because pending of moh approval..if they didnt get the approval..no need to hve hope for this counter